You have 9 free searches left this month | for more free features.

early combined imaging outcomes

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early

Recruiting
  • Metastatic Breast Cancer in the Liver
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 23, 2022

Tooth Extraction, Immediate Implant Placement Trial in Iowa City (Xenogeneic Volume-Stable Collagen (VCMX) graft with growth

Not yet recruiting
  • Tooth Extraction
  • Immediate Implant Placement
  • Xenogeneic Volume-Stable Collagen (VCMX) graft with growth factor-BB
  • Iowa City, Iowa
    University of Iowa College of Dentistry and Dental Clinics
Sep 8, 2023

Research on Patients With Heart Transplantation

Active, not recruiting
  • Heart Transplant Rejection
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Aug 7, 2022

    Cervical Carcinoma, Chemoradiotherapy, Anti-programmed Cell Death Receptor 1 Trial in Beijing (Camrelizumab plus Concurrent

    Recruiting
    • Cervical Carcinoma
    • +8 more
    • Camrelizumab plus Concurrent chemoradiotherapy
    • Beijing, Beijing, China
      Lei Li
    Apr 5, 2022

    Breast Cancer Trial in Halifax (Optical and infrared imaging)

    Recruiting
    • Breast Cancer
    • Optical and infrared imaging
    • Halifax, Nova Scotia, Canada
      Dalhousie University - Radiation Oncology Department
    Mar 1, 2021

    Stroke Trial in Shanghai (Tenecteplase, nonthrombolysis drug)

    Recruiting
    • Stroke
    • Shanghai, Shanghai, China
      Huashan Hospital
    Jul 4, 2022

    Stroke Trial in Shanghai (Low dose tenecteplase, High dose tenecteplase)

    Completed
    • Stroke
    • Low dose tenecteplase
    • High dose tenecteplase
    • Shanghai, Shanghai, China
      Huashan Hospital
    Mar 30, 2022

    Cerebral Palsy, Pediatric Neurological Disorder, Developmental Disability Trial in Marina di Pisa-Tirrenia-Calambrone, Pisa

    Recruiting
    • Cerebral Palsy
    • +2 more
    • Lung Ultrasound (LUS)-monitored feeding trial
    • Marina di Pisa-Tirrenia-Calambrone, Toscana, Italy
    • +1 more
    Jun 20, 2022

    Depressive Disorder, Adolescent Trial in Hangzhou (Fluoxetine, Interpersonal Psychotherapy for Adolescent, Fluoxetine combined

    Recruiting
    • Depressive Disorder
    • Adolescent
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Zhejiang University
    Jul 13, 2023

    Descemet's Stripping Automated Endothelial Keratoplasty

    Completed
    • Corneal Edema Secondary to Corneal Endothelial Dystrophy
    • DSAEK
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center - Aston Ambulatory Clinic
    Nov 17, 2020

    Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Trial in White Plains (Endoscopic Ultrasound, Magnetic Resonance

    Recruiting
    • Pancreatic Cancer
    • +10 more
    • Endoscopic Ultrasound
    • Magnetic Resonance Imaging (MRI)
    • White Plains, New York
      White Plains Hospital
    Mar 10, 2021

    Single and Combined Modality Trans-Oral Robotic Surgery in Early

    Not yet recruiting
    • Cancer Head Neck
    • Molecular Analysis
    • Radiomic/ Morphological analysis
    • (no location specified)
    Jul 3, 2023

    Prostate Cancer, Localized Prostate Carcinoma Trial (PSMA-1007 Positron Emission Tomography (PET) scan)

    Not yet recruiting
    • Prostate Cancer
    • Localized Prostate Carcinoma
    • PSMA-1007 Positron Emission Tomography (PET) scan
    • (no location specified)
    Aug 14, 2023

    Cerebral Small Vessel Diseases, Postmenopausal Symptoms, Mild Cognitive Impairment Trial in Beijing (Estradiol Gel, Estradiol

    Not yet recruiting
    • Cerebral Small Vessel Diseases
    • +3 more
    • Estradiol Gel
    • +3 more
    • Beijing, China
      Beijing Tiantan Hospital
    Aug 6, 2023

    Stroke, Acute Ischemic Trial in Beijing (LF-rTMS, Sham stimulation)

    Not yet recruiting
    • Stroke, Acute Ischemic
    • LF-rTMS
    • Sham stimulation
    • Beijing, Beijing, China
      Beijing Tian tan Hospital
    Sep 26, 2023

    Attention - no Condition is Being Assessed - Healthy Adults Trial in Sacramento (Modafinil)

    Recruiting
    • Attention - no Condition is Being Assessed - Healthy Adults
    • Sacramento, California
      University of California, Davis
    Sep 10, 2023

    Appendicitis Trial in Espoo, Helsinki, Hyvinkää (Abdominal imaging, Score based selective abdominal imaging, Score based

    Not yet recruiting
    • Appendicitis
    • Abdominal imaging
    • +2 more
    • Espoo, Finland
    • +2 more
    Oct 11, 2023

    Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in

    Not yet recruiting
    • Metastatic Triple-Negative Breast Carcinoma
    • 89Zr-atezolizumab PET/CT
    • (no location specified)
    Feb 22, 2023

    Pancreatic Adenocarcinoma Trial in Baltimore (TraceIT tissue marker injection)

    Completed
    • Pancreatic Adenocarcinoma
    • TraceIT tissue marker injection
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Jan 20, 2023

    Heart Failure, Diastolic, Multicenter Study Trial in Beijing

    Recruiting
    • Heart Failure, Diastolic
    • Multicenter Study
      • Beijing, Beijing, China
        Fuwai Hospital
      Apr 14, 2022

      Cancer, Non Small Cell Lung Cancer Trial in Salt Lake City (PET Imaging, Erlotinib, Bevacizumab)

      Completed
      • Cancer
      • Non Small Cell Lung Cancer
      • PET Imaging
      • +2 more
      • Salt Lake City, Utah
        Huntsman Cancer Institute
      Dec 16, 2021

      CMR-AI and Outcomes in Aortic Stenosis

      Not yet recruiting
      • Aortic Stenosis
        • (no location specified)
        Nov 7, 2023

        Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

        Recruiting
        • Melanoma Stage III
        • North Sydney, New South Wales, Australia
          Melanoma Institute Australia
        Oct 26, 2022

        Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • +2 more
        • PDD-TURBT with hexaminolevulinate (Hexvix®)
        • Power Led Saphira (TM) from KARL STORZ
        • (no location specified)
        Jul 24, 2023

        Breast Cancer Trial in Ulm (Determination of tumormarkers (CA27.29, CEA, CA125), Determination of CTC levels, Determination of

        Recruiting
        • Breast Cancer
        • Determination of tumormarkers (CA27.29, CEA, CA125)
        • +3 more
        • Ulm, Germany
          University Hospital Ulm Gynecology/Obstetrics
        Jan 12, 2023